|
Drogenbeauftragte der Bundesregierung. (2004). Drogen- und Suchtbericht 2004. Berlin: Bundesministerium für Gesundheit (BMG).
Keywords: government and politics; AOD use, abuse, and dependence; addiction; monitoring; international area; Germany; annual report
|
|
|
Drogenbeauftragte der Bundesregierung. (2005). Drogen- und Suchtbericht 2005. Berlin: Bundesministerium für Gesundheit (BMG).
Keywords: government and politics; AOD use, abuse, and dependence; addiction; monitoring; international area; Germany; annual report
|
|
|
Drogenbeauftragte der Bundesregierung. (2007). Drogen- und Suchtbericht 2007. Berlin: Bundesministerium für Gesundheit (BMG).
Keywords: government and politics; AOD use, abuse, and dependence; addiction; monitoring; international area; Germany; annual report
|
|
|
Martineau, H., & Gomart, E. (2000). Politiques et expérimentations sur les drogues aux Pays-Bas (Centre de recherches sociologiques sur le droit et les institutions pénales, & Centre de sociologie de l'innovation, Eds.). Paris: Observatoire français des drogues et des toxicomanies (OFDT).
Keywords: government and politics; public policy on AOD; harm reduction; legislation; heroin-assisted treatment; needle distribution and exchange; Netherlands
|
|
|
World Health Organization. (1990). Programme on substance abuse : the content and structure of methadone treatment programmes : a study in six countries (M. Gossop, & M. Grant, Eds.). World Health Organization (WHO).
Keywords: treatment and maintenance; outpatient care
|
|
|
Department of Health of England, Scottish Office Home and Health Department, & Welsh Office. (1991). Drug misuse and dependence : guidelines on clincal management : report of a medical working group. London: Her Majesty's Stationery Office (HMSO).
Keywords: health promotion; recommendations or guidelines; health care professionals; physician; social worker; pharmacist; AOD use, abuse, and dependence; AOD dependent; AOD user; risk assessment; AOD effects and AODR problems; AODR mortality; harm reduction; communicable disease; HIV infection; viral hepatitis; diagnosis; health; mental health; psychological development; hair analysis; urinalysis; hematologic test; treatment and maintenance; drug therapy; intravenous injection; opioids in any form; methadone maintenance; buprenorphine; codeine; naltrexone; clonidine; treatment goals; relapse prevention; international area; United Kingdom; drug substitution therapy
|
|
|
Federal Office of Public Health. (2002). Migration and Public Health : the Confederation's strategic orientation 2002-2006 : summarised version. Berne: Swiss Federal Offfice of Public Health (FOPH).
|
|
|
Rocky Mountain Center for Health Education and Promotion. (2001). Harm reduction : a review of the literature. Lakewood: Rocky Mountain Center for Health Education and Promotion (RMCHEP).
Keywords: harm reduction; prevention; HIV infection; Aids; target group; history; addiction; United States; literature review
|
|
|
Hillebrand, J., Olszewski, D., & Sedefov, R. (2008). GHB and its precursor GBL : an emerging trend case study (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Keywords: addiction; AOD dependence; chemical addiction; drug; gamma-butyrolactone; gamma-hydroxybutyric acid; Europe; study
|
|
|
Olszewski, D., Giraudon, I., Hedrich, D., & Montanari, L. (2009). Women's voices : experiences and perceptions of women who face drug-related problems in Europe (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: Epidemiological studies routinely collect quantitative data on gender differences in drug use (e.g. prevalence, mortality), but far less is published on the qualitative aspects of female drug problems. This review presents quotations gleaned from interviews with women in eight countries. Through these testimonies, the report illustrates how qualitative research can provide glimpses into the experiences and perceptions of women facing drug issues that statistics alone cannot provide.
Keywords: gender; woman; gender differences; AOD use; prevalence; AODR mortality; research; Europe; report
|
|